TheraRadar

Pharma Intelligence, Simplified

← Back
Data updated: Mar 10, 2026

TARO PHARM INDS

NeurologyCardiovascularDermatology
Generics

TARO PHARM INDS is a generic drug manufacturer focused on Neurology, Cardiovascular, Dermatology.

1998
Since
11
Drugs
-
Trials
122
Approved (2yr)

Key Drugs

No active drugs

Recent Activity

LAMOTRIGINE 2026-01-30
Labeling
LAMOTRIGINE 2026-01-30
Labeling
LAMOTRIGINE 2026-01-30
Labeling
LAMOTRIGINE 2026-01-30
Labeling
LAMOTRIGINE 2026-01-30
Labeling
LAMOTRIGINE 2026-01-08
FLUCONAZOLE 2026-01-08
CARBAMAZEPINE 2026-01-05
Labeling
LAMOTRIGINE 2025-12-31
Labeling
FLUTICASONE PROPIONATE 2025-12-16
Manufacturing (CMC)
SEC Filings Pro
Loading...

Therapeutic Focus

Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5

Neurology 40%
2 drugs
Cardiovascular 20%
1 drugs
Dermatology 20%
1 drugs
Immunology 20%
1 drugs

Pipeline Strength Pro

Loading...

Competitors Pro

PAI HOLDINGS PHARM big-pharma
Dermatology, Neurology, Cardiovascular, Immunology
Eli Lilly big-pharma
Immunology, Neurology, Dermatology
BAUSCH specialty
Dermatology, Immunology, Cardiovascular
ADVANZ PHARMA big-pharma
Immunology, Neurology, Cardiovascular, Dermatology
COSETTE other
Cardiovascular, Dermatology, Immunology